FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
    Filters
      Symbols
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan
      Dashboard

      Boehringer, Zealand Obesity Drug’s Weight Loss Disappoints

      Boehringer Ingelheim GmbH’s and Zealand Pharma A/S’s experimental obesity drug survodutide helped patients with diabetes shed as much as 13.1% of their weight, disappointing investors.

      Source: Bloomberg
      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud